2002
DOI: 10.1042/bj20020737
|View full text |Cite
|
Sign up to set email alerts
|

Phosphorylation is required for PMA- and cell-cycle-induced degradation of protein kinase Cδ

Abstract: Classical and novel protein kinase C (PKC) isoforms are down-regulated as a result of chronic activation by certain tumour promoters and physiological stimuli; however, the mechanisms leading to down-regulation are not fully understood. In the present study, we have studied the PMA ('TPA')-induced degradation of PKCdelta in NIH 3T3 cells under culture conditions where PKCdelta displays cell-cycle-dependent down-regulation. In contrast with previous studies, a hyperphosphorylated form of this PKC isoform, promo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0

Year Published

2004
2004
2014
2014

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 43 publications
(47 citation statements)
references
References 35 publications
1
46
0
Order By: Relevance
“…The reasons for this difference are unclear but may relate to the finding that, unlike other isoforms of PKC, PKC requires PMA-induced hyperphosphorylation for down-regulation (Srivastava et al 2002). It is conceivable, therefore, that the enzyme may be less efficiently phosphorylated in HIT-T15 cells, leading to its retention during PMA exposure.…”
Section: Discussionmentioning
confidence: 69%
“…The reasons for this difference are unclear but may relate to the finding that, unlike other isoforms of PKC, PKC requires PMA-induced hyperphosphorylation for down-regulation (Srivastava et al 2002). It is conceivable, therefore, that the enzyme may be less efficiently phosphorylated in HIT-T15 cells, leading to its retention during PMA exposure.…”
Section: Discussionmentioning
confidence: 69%
“…Regardless of the mechanism, these studies suggest that the Transduction Laboratories anti-PKC-␦ antibody is particularly poorly suited to comparing levels of PKC-␦ expression in resting and agonist-activated samples or to examining the relationship between PKC-␦-T 505 phosphorylation and PKC-␦ trafficking and/or downregulation. In this context, it is noteworthy that studies with this reagent have been interpreted as evidence that PKC-␦-T 505 phosphorylation regulates the kinetics of PKC-␦ downregulation (10). Because the BD Transduction Laboratories anti-PKC-␦ artifactually perceives PKC-␦-T 505 (or a related) phosphorylation as a decline in total PKC-␦ protein (which is a cause for concern, given that these experiments were performed with the rat sequence), these studies (as well as others in which this reagent was used to track PKC-␦ protein expression) deserve to be revisited using different methodologies.…”
Section: Specificity Of Bd Transduction Laboratories Anti-pkc-␦mentioning
confidence: 99%
“…The critical role of PKC in EV1 entry and infection was also confirmed in a third set of experiments ( Figure 6C), in which chronic treatment of cells with a phorbol ester (PMA, 6 h) was used to downregulate PKC expression. Chronic PMA treatment is known to induce the degradation of both classical and novel PKCs (Srivastava et al, 2002), and it is not specific for PKC␣. The effectiveness of the treatment was confirmed by Western blotting ( Figure 6C).…”
Section: Protein Kinase C Activity Is Essential For the Internalizatimentioning
confidence: 99%